Loss of ApoA5 predisposed hamsters to HFD-induced more severe HTG and NASH with minor effect on atherogenesis by reducing mRNA of NR1D1 and then impairing NR1D1-mediated metabolic pathways. The gene discussed is NR1D1; the disease is metabolic dysfunction-associated steatohepatitis.